This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Testosterone Enanthate
Bioidentical testosterone in oil depot — gold-standard TRT for documented hypogonadism, but a HPG-suppressing supraphysiologic hammer in…
Aliases (5)
Overview
What is Testosterone Enanthate?
Testosterone enanthate is a long-acting injectable testosterone ester (half-life ~7 days), FDA-approved for hypogonadism. It is essentially interchangeable with testosterone cypionate in clinical practice and is the preferred ester in much of Europe and the UK.
Key Benefits
Restores testosterone in hypogonadism, improves sexual function, mood, energy, and body composition; supports lean mass, bone density, and red blood cell production with once-weekly or twice-weekly dosing.
Mechanism of Action
After IM injection, the enanthate ester is gradually cleaved by plasma esterases, releasing testosterone. Testosterone binds androgen receptors throughout the body, driving anabolic and androgenic gene transcription, and converts to DHT (potent androgen) and estradiol (via aromatase) for additional tissue-specific effects.
Pharmacokinetics
▸ Vial inspection & sterile draw AAS oil
AAS oil arrives pre-suspended in carrier oil — no BAC water needed. Inspect for clarity, color, and crashed compound (cold storage can crystallize). Warm vial in palm or under hot tap before draw.
- 1 Wipe vial stopper with isopropyl alcohol.
- 2 Warm vial 30-60s in palm if oil is cold/cloudy.
- 3 Draw with 18g needle into 22-25g pin barrel for IM, or 27-29g for sub-Q.
- 4 Tap out air bubbles, expel a small drop, then inject at chosen site.
▸ Cycle structure & PCT AAS
Ramp dose over week 1, hold steady through cycle weeks. Track baseline labs (TT/FT/E2/SHBG/HCT/lipids/LFTs) at week 0; recheck at week 4 and end-of-cycle.
On the last dose, the ester clears over its half-life window (enanthate = est. 7 days). PCT begins after the active compound has cleared.
Standard PCT is enclomiphene 12.5-25 mg/day or clomid 50/50/25/25 over 4 weeks (or nolvadex 20/20/10/10). HCG bridge optional during cycle to preserve testicular volume + faster restart. Bloodwork at PCT week 4 + 8 to confirm HPG axis recovery (LH, FSH, TT back to baseline).
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
Manages E2 at supraphysiologic doses. Rarely needed at TRT doses.
Maintains testicular volume + intratesticular T for fertility preservation in younger TRT patients.
Used for hair preservation but blocks 5α-reductase → may attenuate anabolic effect in muscle (controversial) and has its own neuroendocrine side effect profi…
Hepatotoxic 17α-alkylated oral; redundant + dangerous combo.
Less hepatotoxic but still 17α-alkylated; HDL crash risk compounds.
Each adds specific harms (Tren = neuro/CV/sleep; Deca = prolactin + "deca dick" + much longer suppression).
Compounds CV strain (HR + BP + Hct).
Quality Indicators
White, fluffy cake (peptides)
Lyophilized peptide should appear as a white, fluffy "cake" filling most of the vial bottom. Indicates proper freeze-drying.
Clear solution after reconstitution
After mixing with bacteriostatic water, the solution should be crystal clear with no particles or cloudiness.
Slight clumping acceptable
Small clumps that fully dissolve with gentle swirling are normal — shipping can cause minor compaction.
Collapsed or melted powder
Powder that looks collapsed, melted, or stuck to vial sides may have been heat-damaged in transit.
Cloudy or particulate solution
Persistent cloudiness or visible particles after gentle mixing indicate degraded or contaminated material.
What to Expect
- Onset(TRT 100-200 mg/wk): Subtle. Energy, morning erections, sleep quality improve over 2-6 weeks. Body comp shifts over 3-6 months.
- Onset(supraphysiologic 400-600 mg/wk): Within 1-2 weeks: noticeable libido + drive surge, training aggression, faster recovery between sessions, water retention, …
- PeakPlateau by ~week 4-6. Sustained anabolic effect persists for the cycle duration.
- Taper/ post-cycle: Without PCT, crash in ~2-3 weeks post-last-injection. Profound fatigue, libido collapse, depressed mood, fat regain, strength loss for 1-6 mont…
Side Effects & Safety
- Common (>10% users):
- Testicular atrophy (universal at suppressive doses)
- Decreased spermatogenesis / oligospermia / azoospermia
- Acne, oily skin
- Water retention / edema (E2-mediated)
- Increased hematocrit / hemoglobin
- Injection site soreness (PIP — post-injection pain)
- Less common (1-10%):
- Gynecomastia (E2-driven, especially without AI in supra dosing)
- Mood lability / irritability / aggression ("roid rage" — variable, dose-dependent)
- Sleep apnea worsening
- Accelerated androgenic alopecia (in genetically susceptible)
- Lipid panel deterioration (HDL ↓, LDL/ApoB ↑)
- Suppressed HDL particularly with oral 17α-alkylated stacks; less severe but real with injectables
- Rare-serious (<1% but worth knowing):
- Polycythemia → thromboembolic risk (DVT, PE, stroke). Phlebotomy/dose reduction if Hct >54%.
- Cardiomyopathy / LVH at chronic supraphysiologic exposure (years).
- Permanent fertility loss (reported even after PCT in some cases).
- Prostate hypertrophy / unmasking of subclinical prostate cancer.
- Sterile abscess at injection site (poor technique / contaminated gear).
- Hepatic effects: minimal with injectables (vs oral 17α-alkylated like methyltestosterone).
- Specific watch periods:
- First 8-12 weeks: monitor hematocrit, E2, libido response, mood.
- 3 months in: full lipid + comprehensive panel.
- Annually: PSA (if >40 or family hx), DRE per AUA.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.